Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
https://doi.org/10.2337/dc22-1399
Related Questions
Do you avoid empagliflozin in patients with history of amputation?
Do you recommend continuous glucose monitoring for patients with Type 2 diabetes who are not on insulin?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Should GLP1 R agonists be used as first line glucose lowering agents in patients with ESKD and DM2?
What is the clinical importance of differentiating between impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) states?
Do you routinely monitor INR when starting GLP1 R agonist therapy on patients taking warfarin?
How do you adjust your HbA1c goal for managing diabetes in elderly patients with multiple chronic illnesses but no limitations in performing self-care tasks?
When should metformin be stopped before surgery and when is it considered safe to resume?
What is the recommended frequency and duration of exercise bouts in order to sustain the beneficial effects of exercise on insulin sensitivity?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?
